168 related articles for article (PubMed ID: 10741711)
1. In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002).
Hu L; Zaloudek C; Mills GB; Gray J; Jaffe RB
Clin Cancer Res; 2000 Mar; 6(3):880-6. PubMed ID: 10741711
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
Hu L; Hofmann J; Lu Y; Mills GB; Jaffe RB
Cancer Res; 2002 Feb; 62(4):1087-92. PubMed ID: 11861387
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinoma.
Hu L; Hofmann J; Jaffe RB
Clin Cancer Res; 2005 Nov; 11(22):8208-12. PubMed ID: 16299254
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of tirapazamine combined with phosphatidylinositol 3-kinase inhibitor LY294002 to ovarian cancer cells].
Ren Y; Zha X; Zhang GN
Zhonghua Yi Xue Za Zhi; 2007 May; 87(17):1204-6. PubMed ID: 17686243
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of human malignant glioma cells induced by the PI3-K-specific inhibitor.
Shingu T; Yamada K; Hara N; Moritake K; Osago H; Terashima M; Uemura T; Yamasaki T; Tsuchiya M
J Neurosurg; 2003 Jan; 98(1):154-61. PubMed ID: 12546364
[TBL] [Abstract][Full Text] [Related]
6. [Expression of phosphatidylinositol-3 kinase in epithelial ovarian carcinoma].
Zhang PN; Sun H
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):196-200. PubMed ID: 17537308
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of phosphatidylinositol 3-kinase/Akt and histone deacetylase activity induces apoptosis in non-small cell lung cancer in vitro and in vivo.
Denlinger CE; Rundall BK; Jones DR
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1422-9. PubMed ID: 16256798
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer.
Hu L; Hofmann J; Zaloudek C; Ferrara N; Hamilton T; Jaffe RB
Am J Pathol; 2002 Nov; 161(5):1917-24. PubMed ID: 12414537
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
Mabuchi S; Ohmichi M; Nishio Y; Hayasaka T; Kimura A; Ohta T; Kawagoe J; Takahashi K; Yada-Hashimoto N; Seino-Noda H; Sakata M; Motoyama T; Kurachi H; Testa JR; Tasaka K; Murata Y
Clin Cancer Res; 2004 Nov; 10(22):7645-54. PubMed ID: 15569997
[TBL] [Abstract][Full Text] [Related]
10. The targeting of phosphoinositide-3 kinase attenuates pulmonary metastatic tumor growth following laparotomy.
Coffey JC; Wang JH; Bouchier-Hayes D; Cotter TG; Redmond HP
Ann Surg; 2006 Feb; 243(2):250-6. PubMed ID: 16432359
[TBL] [Abstract][Full Text] [Related]
11. PIK3CA is implicated as an oncogene in ovarian cancer.
Shayesteh L; Lu Y; Kuo WL; Baldocchi R; Godfrey T; Collins C; Pinkel D; Powell B; Mills GB; Gray JW
Nat Genet; 1999 Jan; 21(1):99-102. PubMed ID: 9916799
[TBL] [Abstract][Full Text] [Related]
12. Role of triptolide as an adjunct chemotherapy for ovarian cancer.
Westfall SD; Nilsson EE; Skinner MK
Chemotherapy; 2008; 54(1):67-76. PubMed ID: 18073474
[TBL] [Abstract][Full Text] [Related]
13. LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells.
Curnock AP; Knox KA
Cell Immunol; 1998 Aug; 187(2):77-87. PubMed ID: 9732695
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 3-kinase inhibitors are a triple threat to ovarian cancer.
Parsons R
Clin Cancer Res; 2005 Nov; 11(22):7965-6. PubMed ID: 16299225
[No Abstract] [Full Text] [Related]
15. [Effects of combined therapy of LY294002 and SN50 on nude mice model with gastric cancer].
Sun JL; Zhu BS; Gong W; Zhang P; Yu LY; Zhao K; Xing CG
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 May; 14(5):364-7. PubMed ID: 21614693
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of phosphatidylinositol 3-kinase sensitizes ovarian cancer cells to carboplatin and allows adjunct chemotherapy treatment.
Westfall SD; Skinner MK
Mol Cancer Ther; 2005 Nov; 4(11):1764-71. PubMed ID: 16275998
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines.
Lee CM; Fuhrman CB; Planelles V; Peltier MR; Gaffney DK; Soisson AP; Dodson MK; Tolley HD; Green CL; Zempolich KA
Clin Cancer Res; 2006 Jan; 12(1):250-6. PubMed ID: 16397049
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinase inhibitor(LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo.
Jiang H; Fan D; Zhou G; Li X; Deng H
J Exp Clin Cancer Res; 2010 Apr; 29(1):34. PubMed ID: 20412566
[TBL] [Abstract][Full Text] [Related]
19. An inhibitor of PI3-K differentially affects proliferation and IL-6 protein secretion in normal and leukemic myeloid cells depending on the stage of differentiation.
Birkenkamp KU; Esselink MT; Kruijer W; Vellenga E
Exp Hematol; 2000 Nov; 28(11):1239-49. PubMed ID: 11063872
[TBL] [Abstract][Full Text] [Related]
20. The phosphatidylinositol 3-kinase inhibitor LY294002 binds the estrogen receptor and inhibits 17beta-estradiol-induced transcriptional activity of an estrogen sensitive reporter gene.
Pasapera Limón AM; Herrera-Muñoz J; Gutiérrez-Sagal R; Ulloa-Aguirre A
Mol Cell Endocrinol; 2003 Feb; 200(1-2):199-202. PubMed ID: 12644312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
